“OLIG2 Expression Level Could Be Used As an Independent Prognostic Factor for Patients With Cerebellar Glioblastoma (cGBM)”. Clinics 78 (March 30, 2023): 100120. Accessed May 9, 2024. https://www.journals.usp.br/clinics/article/view/213766.